Salim Abdool Karim

Salim Abdool Karim
Nikita Devnarain · CC BY-SA 4.0 · source
Name	Salim Abdool Karim
Birth date	1960
Birth place	Durban, South Africa
Nationality	South Africa
Fields	Medicine, Epidemiology, Infectious diseases
Institutions	University of KwaZulu-Natal, Centre for the AIDS Programme of Research in South Africa, World Health Organization
Alma mater	University of Natal, University of London
Known for	HIV/AIDS research, COVID-19 public health leadership

Contents

Salim Abdool Karim is a South African physician, epidemiologist and researcher noted for leadership in HIV/AIDS science and pandemic policy. He has held academic posts at the University of KwaZulu-Natal and directed the Centre for the AIDS Programme of Research in South Africa (CAPRISA), while advising national and international bodies including the South African Government, the World Health Organization and the Bill & Melinda Gates Foundation. His work spans clinical trials, translational research and public health strategy with global collaborations involving institutions such as Harvard University, Columbia University and the National Institutes of Health.

Early life and education

Born in Durban, he trained in medicine at the University of Natal before postgraduate study at the London School of Hygiene & Tropical Medicine and research at the University of London. He completed specialist training in infectious diseases and clinical epidemiology with mentorship from physicians and scientists affiliated to Imperial College London, Oxford University, and the University of Cape Town. Early contacts included networks linking European Union research programmes, the Wellcome Trust, and the Rockefeller Foundation, which shaped his interdisciplinary approach combining clinical practice at hospitals such as King Edward VIII Hospital with laboratory science at centres like the National Institute for Communicable Diseases.

His research portfolio encompassed HIV prevention, microbicides, antiretroviral therapy, and mother-to-child transmission studies, working with consortia including the International AIDS Society, the African Academy of Sciences, and the Wellcome Trust. He led or co-led pivotal clinical trials in KwaZulu-Natal evaluating interventions with agents from Gilead Sciences, Johnson & Johnson, and public health strategies promoted by UNAIDS. He contributed to epidemiological analyses with collaborators at Johns Hopkins University, Imperial College London, Columbia University Mailman School of Public Health, and the London School of Hygiene & Tropical Medicine that influenced national programmes run by the South African Department of Health and regional initiatives coordinated by the African Union and the Southern African Development Community. His work intersects with vaccine research undertaken at the HIV Vaccine Trials Network, prevention science from the Bill & Melinda Gates Foundation, and policy dialogues shaped at forums such as the World Economic Forum and the United Nations General Assembly.

He served on national and provincial advisory committees during the COVID‑19 pandemic, advising President Cyril Ramaphosa's administration alongside technical groups linked to the National Institute for Communicable Diseases, the South African Health Products Regulatory Authority, and provincial health departments in KwaZulu-Natal. Internationally he provided expertise to the World Health Organization and participated in collaborative research with teams at Imperial College London, University College London, Harvard T.H. Chan School of Public Health, and the London School of Hygiene & Tropical Medicine on modelling, vaccine rollout, and variant surveillance including work involving the Network for Genomic Surveillance in South Africa. His public health leadership drew on previous epidemic responses such as engagements with UNAIDS, responses to tuberculosis co-infection patterns studied with the Stop TB Partnership, and liaison with pharmaceutical regulators like the European Medicines Agency and the United States Food and Drug Administration.

He has received national and international awards and memberships, including election to bodies such as the Royal Society, the Academy of Science of South Africa, and honorary degrees from institutions like the University of Oxford, Yale University, and the University of Cape Town. His honours include recognitions from organisations such as the Wellcome Trust, the Bill & Melinda Gates Foundation, the International AIDS Society, and the Royal College of Physicians. He has been listed among influential figures by the World Health Organization and profiled by media outlets including The Lancet, Nature, Science, The New York Times, and The Guardian for contributions to HIV/AIDS and pandemic response.

He has held board and advisory positions with international bodies including the World Health Organization, the Bill & Melinda Gates Foundation, the Global Fund to Fight AIDS, Tuberculosis and Malaria, and the Wellcome Trust. He maintains academic appointments at the University of KwaZulu-Natal and affiliations with research networks such as the African Academy of Sciences, the International AIDS Society, and the HIV Vaccine Trials Network. Personal connections span collaborations with scientists at Harvard University, Johns Hopkins University, Imperial College London, University of Cape Town, and policy-makers including Cyril Ramaphosa and other leaders in South African politics.

Category:South African physicians Category:Epidemiologists